Viromed Medical AG | WebDisclosure

PRESS RELEASE

published on 07/29/2025 at 14:08, 7 months 21 days ago

Viromed Medical AG: Annual General Meeting approves all proposed resolutions by a large majority
Viromed Medical AG's Annual General Meeting approves all proposed resolutions by a large majority. New Supervisory Board member elected, authorised capital replaced, and focus on innovation highlighted

Annual General Meeting Resolutions Strategic Direction Viromed Medical AG Cold Plasma Technology
BRIEF

published on 07/24/2025 at 09:35, 7 months 26 days ago

Viromed Medical AG Teams Up with TriPart for Product Launch in Turkey

Medical Devices Viromed Medical AG Cold Plasma Technology TriPart Partnership Market Expansion Turkey
BRIEF

published on 07/24/2025 at 09:35, 7 months 26 days ago

Viromed Medical AG s'associe à TriPart pour le lancement de son produit en Turquie

Dispositifs Médicaux Viromed Medical AG Technologie Du Plasma Froid Partenariat TriPart Expansion Du Marché En Turquie
PRESS RELEASE

published on 07/24/2025 at 09:30, 7 months 26 days ago

Viromed Medical AG enters into a distribution partnership with TriPart for the market launch of ViroCAP® and PulmoPlas® in Turkey
Viromed Medical AG partners with TriPart for market launch of ViroCAP® and PulmoPlas® in Turkey. New distribution agreement to introduce innovative medical technology products in Q1 2026

Distribution Partnership Viromed Medical AG ViroCAP PulmoPlas TriPart
BRIEF

published on 06/30/2025 at 15:41, 8 months 19 days ago

Viromed Medical AG Projects Significant Growth for 2025 and 2026

Revenue Growth Product Launch Viromed Medical AG Cold Plasma Technology Pharmedix Acquisition
BRIEF

published on 06/30/2025 at 15:41, 8 months 19 days ago

Viromed Medical AG prévoit une croissance significative pour 2025 et 2026

Croissance Des Revenus Lancement De Produit Viromed Medical AG Technologie Du Plasma Froid Acquisition De Pharmedix
PRESS RELEASE

published on 06/30/2025 at 15:36, 8 months 19 days ago

EQS-Adhoc: Viromed Medical AG expects dynamic growth and announces forecast for 2025 and 2026
Viromed Medical AG expects dynamic growth with revenue forecasted to reach around EUR 8-10 million in 2025 and around EUR 80 million in 2026. The EBIT margin is expected to be in the double-digit range from 2026 onwards

Revenue Forecast Dynamic Growth Financial Projections Viromed Medical AG Cold Plasma Technology
BRIEF

published on 06/23/2025 at 10:07, 8 months 26 days ago

La technologie du plasma froid de Viromed Medical AG s'avère prometteuse pour réduire la mortalité chez les patients ventilés

Approbation Accélérée Viromed Medical AG Pneumonie Associée À La Ventilation Mécanique Technologie Du Plasma Froid Réduction De La Mortalité
BRIEF

published on 06/23/2025 at 10:07, 8 months 26 days ago

Viromed Medical AG's Cold Plasma Technology Shows Promise in Reducing Deaths in Ventilated Patients

Viromed Medical AG Ventilator-associated Pneumonia Cold Plasma Technology Mortality Reduction Fast-track Approval
PRESS RELEASE

published on 06/23/2025 at 10:02, 8 months 26 days ago

Viromed Medical AG: Cold plasma technology shows potential to significantly reduce deaths in ventilated patients
Viromed Medical AG's cold plasma technology shows potential to significantly reduce deaths in ventilated patients according to preclinical study, addressing a critical issue in intensive care medicine

Preclinical Study Viromed Medical AG Ventilator-associated Pneumonia Cold Plasma Technology Intensive Care Medicine

Published on 03/19/2026 at 21:16, 1 hour 15 minutes ago

Unusual Machines, Inc. Announces Proposed Public Offering
Published on 03/19/2026 at 14:20, 8 hours 11 minutes ago

CBMJ CEO Rips Legacy Liberal Media Over Iran Coverage on The Schaftlein Report
Published on 03/19/2026 at 13:50, 8 hours 41 minutes ago

Predictiv AI Appoints Multi-Agent Systems Pioneer Professor George Rzevski as Strategic Advisor to Advance Swarm AI Platforms
Published on 03/19/2026 at 13:30, 9 hours 1 minute ago

Hillcrest Energy Technologies CEO Don Currie Discusses ZVS Technology and Commercialization Progress in Stocks To Watch Investor Interview
Published on 03/19/2026 at 13:30, 9 hours 1 minute ago

ACCESS Newswire Reports Fourth Quarter and Full Year 2025 Results

View all ACCESSWIRE

Published on 03/19/2026 at 19:30, 3 hours 1 minute ago

EEII AG: Publication of Listing Prospectus
Published on 03/19/2026 at 19:24, 3 hours 6 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/19/2026 at 18:45, 3 hours 46 minutes ago

Stabilisation Notice
Published on 03/19/2026 at 18:26, 4 hours 4 minutes ago

Malteries Franco Belges S.A.: Résultats du 1er semestre 2025/2026 et mise à disposition du rapport financier semestriel
Published on 03/19/2026 at 18:18, 4 hours 12 minutes ago

VINCORION SE successfully completes Initial Public Offering

View all EQS

Published on 03/19/2026 at 18:00, 4 hours 31 minutes ago

Filing of the 2025 Universal Registration Document
Published on 03/19/2026 at 18:00, 4 hours 31 minutes ago

Mise à disposition du Document d’Enregistrement Universel 2025
Published on 03/19/2026 at 15:00, 7 hours 31 minutes ago

Statement Accor
Published on 03/19/2026 at 15:00, 7 hours 31 minutes ago

Communication Accor
Published on 03/19/2026 at 08:45, 13 hours 46 minutes ago

Deezer et Sonos renouvellent et étendent leur partenariat stratégique

View all LES ECHOS COMFI WIRE

News